Difference between revisions of "Pharm Tech Agenda 2015.03.11"
Jump to navigation
Jump to search
Line 38: | Line 38: | ||
=== Review of CMPD Profile document === | === Review of CMPD Profile document === | ||
* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/IHE_Pharmacy_Suppl_CMPD_Rev1.5_TI_2015-03-10.docx Draft here] | * [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/IHE_Pharmacy_Suppl_CMPD_Rev1.5_TI_2015-03-10.docx Draft here] | ||
− | |||
== Profile == | == Profile == |
Revision as of 10:19, 10 March 2015
Meeting details
Wednesday, 11 March 2015, 14:00 CET
WebEx details:
Meeting number: 959 390 393
Call-in Numbers: Global Call-in numbers
Agenda
Review of MTP Profile document
- Glossary & definitions (pages 8, 10, 25)
- Reported medications (page 16)
- Next steps
Review of CPs
- CP mtp-pre-1: link PRE --> MTP & type of referenced content
- Draft here
- Goal: distinguish between reference to PRE and reference to MTP (same content)
- CP mtp-pre-2: Reference to original CDA document (when in PML)
- Draft here
- Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document
- Useful also for DIS and PADV?